Statistics for iRadimed (id:5324 IRMD)
Valuation metrics
Market cap
691,59M
Enterprise value
624,67M
Trailing P/E (ttm)
37,38
Forward P/E
31,18
PEG ratio
31,18
Price/Sales (ttm)
9,70
Price/Book (mrq)
8,29
Enterprise Value/Revenue
8,76
Enterprise Value/EBITDA
28,20
Overview
Shares outstanding
12,67M
Float
7,11M
Shares short
86,06K
% Held by insiders
3,00%
% Held by institutions
3,00%
Average volume (10 days)
54,65K
Average volume (90 days)
Price summary
52-Week low
40,18
52-Week high
58,41
52-Week change
20,85%
Beta
3,00
50-Day moving average
52,79
200-Day moving average
46,60
Dividends and splits
Forward annual dividend rate
3,00
Forward annual dividend yield
5,00
Trailing annual dividend rate
3,00%
Trailing annual dividend yield
5,00
5-Year annual dividend yield
Payout ratio
3,00
Dividend date
November 25, 2024
Ex-dividend date
November 15, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
26,12%
Operating margin
31,59%
Operational effectiveness
Return on assets
14,67%
Return on equity
23,58%
Income statement
Revenue (ttm)
5,64
Revenue per share (ttm)
5,64
Quarterly revenue growth (yoy)
5,00
Gross profit (ttm)
50,16M
EBITDA
22,15M
Net income to common (ttm)
18,63M
Diluted EPS (ttm)
1,46
Quarterly earnings growth (yoy)
3,00%
Balance sheet
Total cash (mrq)
51,72M
Total cash per share (mrq)
4,08
Total debt (mrq)
264,08K
Total Debt/Equity (mrq)
3,00
Current ratio (mrq)
921,30%
Book value per share (mrq)
6,58
Cash flow
Cash flow statement
23,55M
Levered free cash flow (LFCF)
13,14M